This month, Congressional committees held a number of hearings that focused on health policy issues, including the following:

  • House Energy & Commerce Committee hearings on the drug supply chain and patient brokering/addiction treatment fraud.
  • Senate Health, Education, Labor, and Pensions (HELP) Committee hearings on the cost of prescription drugs and implementation of the 21st Century Cures Act, including a hearing concentrating on the Act’s mental health-related provisions.
  • A Senate Judiciary Committee oversight hearing on the “Ensuring Patient Access and Effective Drug Enforcement Act.”